Advances in the identification and validation of autism biomarkers

Beth Oakley, Eva Loth, Emily Jones, Christopher Chatham, Declan Murphy

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)


A decade on from the launch of the pioneering autism biomarker discovery initiative EU-AIMS, here we highlight advances in biomarker discovery and validation from the follow-on AIMS-2-TRIALS programme, which aims to improve the wellbeing and outcomes of autistic people through precision healthcare approaches.

Original languageEnglish
Pages (from-to)697-698
Number of pages2
JournalNature Reviews Drug Discovery
Issue number10
Publication statusPublished - Oct 2022


Dive into the research topics of 'Advances in the identification and validation of autism biomarkers'. Together they form a unique fingerprint.

Cite this